Better Antibiotic Prescribing Through Action Research (BAbAR)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03082521|
Recruitment Status : Enrolling by invitation
First Posted : March 17, 2017
Last Update Posted : April 29, 2019
|Condition or disease||Intervention/treatment|
|Infectious Disease||Behavioral: Improving the antibiotic prescribing quality|
|Study Type :||Observational [Patient Registry]|
|Estimated Enrollment :||170 participants|
|Target Follow-Up Duration:||4 Years|
|Official Title:||Better Antibiotic Prescribing Through Action Research|
|Actual Study Start Date :||April 1, 2017|
|Estimated Primary Completion Date :||March 15, 2021|
|Estimated Study Completion Date :||October 1, 2023|
- Behavioral: Improving the antibiotic prescribing quality
The goal is to improve the antibiotic prescribing quality of GPs in a GPC by setting up a participatory action research. The interventions will be co-designed with the GPs.
- Interview study [ Time Frame: year 1 ]Semi-structured interview with the stakeholders on the experiences of prescribing antibiotics in OOH care and the willingness to participate in PAR.
- Antibiotic prescribing feedback using antibiotic prescribing quality indicators [ Time Frame: year 1 ]
Using antibiotic prescribing quality indicators (APQI) feedback on the antibiotic prescription rates of the GPC will be generated. For the six most common indications for antibiotic prescribing (in descending order: acute bronchitis (ICPC (6) code R78), acute upper RTI (R74), cystitis/other urinary infection (UTI; U71), acute tonsillitis (R76), acute/chronic sinusitis (R75), and acute otitis media (H71)) and for pneumonia (R81) values of three valid antibiotic prescribing quality indicators (APQI)quality indicators will be calculated and fed back: (5)
- = the percentage of patients with age and/or gender limitation prescribed an antibiotic;
- = a. and receiving the guideline recommended antibiotic;
- = a and receiving quinolones.
- Ethnographic study: explanatory and descriptive approach of observations, descriptions and interpretation of the phenomenon of prescribing antibiotics in OOH care [ Time Frame: year 2 ]Observations of consultations to get a better understanding of the context , difficulties, clinical issues, etc. of prescribing antibiotics in OOH care.
- Focus groups (descriptative & interpretative) & description of PDSA cycles on developing and implementing interventions on antibiotic prescribing in OOH care [ Time Frame: year 3 ]
Qualitative and quantitative results of phase 1 will be fedback to the group of GPs. In reflective peer group sessions the issues and problems will be explored and interventions will be designed taking into account previous work.
The implemented interventions and changes will be studied based on both outcome as process indicators. ESACs' Antibiotic Prescribing Quality Indicators (APQI) will be used to assess quality of antibiotic prescribing. Pocess indicators will depend on the chosen interventions.
- Process evaluation and sociological meso-theory building of PAR in the case of improving antibiotic prescribing behaviour in a GPC [ Time Frame: year 4 ]Evaluation of the study, theory building on optimising antibiotic use with PAR. Study of group-level interactions, descriptive.
- Use of Antibiotics (quantity, type, use of broad-spectrum antibiotics,etc.) in daytime care [ Time Frame: year 5 ]The use of antiobiotics during office hours to assess any spill over effect of PAR in OOH-care.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03082521
|Study Chair:||Samuel Coenen, MD, PhD||Universiteit Antwerpen|
|Study Chair:||Sibyl Anthierens, PhD||Universiteit Antwerpen|